PHILADELPHIA CHROMOSOME POSITIVE
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to control tough leukemia
Disease control Recruiting nowThis study tests whether combining two drugs, blinatumomab and asciminib, can help control Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults. About 40 participants will receive the combination to see if it is safe and effective. The goal is to mana…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:29 UTC
-
New combo tackles resistant leukemia in phase 2 trial
Disease control Recruiting nowThis study tests a combination of two drugs—blinatumomab and ponatinib—along with chemotherapy in adults with a specific type of leukemia (Ph-positive ALL) that has come back or not responded to prior treatment. The goal is to see if this approach can improve response rates and s…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:19 UTC
-
New drug combo aims to improve control of chronic myeloid leukemia
Disease control Recruiting nowThis study is testing whether adding a chemotherapy drug (ASTX727) to a standard targeted therapy (dasatinib) can better control chronic myeloid leukemia (CML) in people newly diagnosed. About 70 adults with a specific genetic form of CML will receive both drugs. The goal is to s…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Heart shield: new study tests drug to prevent chemo side effects
Disease control Recruiting nowThis study tests whether a drug called dexrazoxane can protect the heart from damage caused by chemotherapy in people with certain blood cancers, like acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). About 100 participants will receive dexrazoxane alongs…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC